BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29432335)

  • 1. Extracellular Matrix Regulation and Dysregulation in Exfoliation Syndrome.
    Zenkel M
    J Glaucoma; 2018 Jul; 27 Suppl 1():S24-S28. PubMed ID: 29432335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
    Zenkel M; Schlötzer-Schrehardt U
    J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
    Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
    Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The composition of exfoliation material and the cells involved in its production.
    Zenkel M; Schlötzer-Schrehardt U
    J Glaucoma; 2014; 23(8 Suppl 1):S12-4. PubMed ID: 25275897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of exfoliative glaucoma.
    Ritch R
    Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
    Schlötzer-Schrehardt U
    Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma.
    Schlötzer-Schrehardt U; Zenkel M
    Exp Eye Res; 2019 Dec; 189():107818. PubMed ID: 31563608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.
    Zenkel M; Kruse FE; Jünemann AG; Naumann GO; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1982-90. PubMed ID: 16639006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composition of Exfoliation Material.
    Challa P; Johnson WM
    J Glaucoma; 2018 Jul; 27 Suppl 1():S29-S31. PubMed ID: 29965899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exfoliation syndrome: assembling the puzzle pieces.
    Pasquale LR; Borrás T; Fingert JH; Wiggs JL; Ritch R
    Acta Ophthalmol; 2016 Sep; 94(6):e505-12. PubMed ID: 26648185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compositional Analysis of Extracellular Aggregates in the Eyes of Patients With Exfoliation Syndrome and Exfoliation Glaucoma.
    De Maria A; Zientek KD; David LL; Wilmarth PA; Bhorade AM; Harocopos GJ; Huang AJW; Hong AR; Siegfried CJ; Tsai LM; Sheybani A; Bassnett S
    Invest Ophthalmol Vis Sci; 2021 Dec; 62(15):27. PubMed ID: 34964803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth Factors, Oxidative Damage, and Inflammation in Exfoliation Syndrome.
    Borrás T
    J Glaucoma; 2018 Jul; 27 Suppl 1(Suppl 1):S54-S60. PubMed ID: 29401156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Glaucoma in Exfoliation Syndrome.
    Ozaki M
    J Glaucoma; 2018 Jul; 27 Suppl 1():S83-S86. PubMed ID: 29432334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.
    Bernstein AM; Ritch R; Wolosin JM
    J Glaucoma; 2018 Jul; 27 Suppl 1(Suppl 1):S44-S53. PubMed ID: 29547474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression in pseudoexfoliation syndrome.
    Zenkel M; Pöschl E; von der Mark K; Hofmann-Rummelt C; Naumann GO; Kruse FE; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3742-52. PubMed ID: 16186358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of Exfoliation Syndrome.
    Aung T; Chan AS; Khor CC
    J Glaucoma; 2018 Jul; 27 Suppl 1():S12-S14. PubMed ID: 29965897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exfoliation syndrome.
    Ritch R; Schlötzer-Schrehardt U
    Surv Ophthalmol; 2001; 45(4):265-315. PubMed ID: 11166342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Biology of Exfoliation Syndrome.
    Schlötzer-Schrehardt U
    J Glaucoma; 2018 Jul; 27 Suppl 1():S32-S37. PubMed ID: 29419649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathology of Exfoliation Syndrome.
    Kivelä TT
    J Glaucoma; 2018 Jul; 27 Suppl 1():S38-S43. PubMed ID: 29595556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why is glaucoma associated with exfoliation syndrome?
    Ritch R; Schlötzer-Schrehardt U; Konstas AG
    Prog Retin Eye Res; 2003 May; 22(3):253-75. PubMed ID: 12852486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.